[(1R,2S)-2-[[8-carbamoyl-7-[[5-(5-morpholin-4-yl-7-oxofuro[3,2-b]pyran-3-yl)-1H-indazol-7-yl]methyl]-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]amino]cyclohexyl]azanium

C31H33N10O5+ — CID 146900585

IUPAC[(1R,2S)-2-[[8-carbamoyl-7-[[5-(5-morpholin-4-yl-7-oxofuro[3,2-b]pyran-3-yl)-1H-indazol-7-yl]methyl]-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]amino]cyclohexyl]azanium
SMILESNC(=O)c1c(Cc2cc(-c3coc4c(=O)cc(N5CCOCC5)oc34)cc3cn[nH]c23)nc(N[C@H]2CCCC[C@H]2[NH3+])n2cnnc12
InChIInChI=1S/C31H32N10O5/c32-20-3-1-2-4-21(20)36-31-37-22(25(29(33)43)30-39-35-15-41(30)31)11-17-9-16(10-18-13-34-38-26(17)18)19-14-45-28-23(42)12-24(46-27(19)28)40-5-7-44-8-6-40/h9-10,12-15,20-21H,1-8,11,32H2,(H2,33,43)(H,34,38)(H,36,37)/p+1/t20-,21+/m1/s1
InChIKeyIYMHCMDQQVEQGZ-RTWAWAEBSA-O
MW625.67 g/mol
LogP1.86
Rot. Bonds7

About [(1R,2S)-2-[[8-carbamoyl-7-[[5-(5-morpholin-4-yl-7-oxofuro[3,2-b]pyran-3-yl)-1H-indazol-7-yl]methyl]-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]amino]cyclohexyl]azanium

[(1R,2S)-2-[[8-carbamoyl-7-[[5-(5-morpholin-4-yl-7-oxofuro[3,2-b]pyran-3-yl)-1H-indazol-7-yl]methyl]-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]amino]cyclohexyl]azanium (PubChem CID 146900585) has the molecular formula C31H33N10O5+ and a molecular weight of 625.67 g/mol. Its IUPAC name is [(1R,2S)-2-[[8-carbamoyl-7-[[5-(5-morpholin-4-yl-7-oxofuro[3,2-b]pyran-3-yl)-1H-indazol-7-yl]methyl]-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]amino]cyclohexyl]azanium.

Molecular Properties

Compound Name[(1R,2S)-2-[[8-carbamoyl-7-[[5-(5-morpholin-4-yl-7-oxofuro[3,2-b]pyran-3-yl)-1H-indazol-7-yl]methyl]-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]amino]cyclohexyl]azanium
PubChem CID146900585
Molecular FormulaC31H33N10O5+
Molecular Weight625.67 g/mol
Exact Mass625.26
IUPAC Name[(1R,2S)-2-[[8-carbamoyl-7-[[5-(5-morpholin-4-yl-7-oxofuro[3,2-b]pyran-3-yl)-1H-indazol-7-yl]methyl]-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]amino]cyclohexyl]azanium
SMILESNC(=O)c1c(Cc2cc(-c3coc4c(=O)cc(N5CCOCC5)oc34)cc3cn[nH]c23)nc(N[C@H]2CCCC[C@H]2[NH3+])n2cnnc12
InChIInChI=1S/C31H32N10O5/c32-20-3-1-2-4-21(20)36-31-37-22(25(29(33)43)30-39-35-15-41(30)31)11-17-9-16(10-18-13-34-38-26(17)18)19-14-45-28-23(42)12-24(46-27(19)28)40-5-7-44-8-6-40/h9-10,12-15,20-21H,1-8,11,32H2,(H2,33,43)(H,34,38)(H,36,37)/p+1/t20-,21+/m1/s1
InChIKeyIYMHCMDQQVEQGZ-RTWAWAEBSA-O
XLogP1.86
TPSA210.34 Ų
H-Bond Donors4
H-Bond Acceptors12
Rotatable Bonds7
Heavy Atoms46
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500625.67
LogP ≤ 51.86
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1012

Analyze [(1R,2S)-2-[[8-carbamoyl-7-[[5-(5-morpholin-4-yl-7-oxofuro[3,2-b]pyran-3-yl)-1H-indazol-7-yl]methyl]-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]amino]cyclohexyl]azanium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1R,2S)-2-[[8-carbamoyl-7-[[5-(5-morpholin-4-yl-7-oxofuro[3,2-b]pyran-3-yl)-1H-indazol-7-yl]methyl]-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]amino]cyclohexyl]azanium?
The IUPAC name of [(1R,2S)-2-[[8-carbamoyl-7-[[5-(5-morpholin-4-yl-7-oxofuro[3,2-b]pyran-3-yl)-1H-indazol-7-yl]methyl]-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]amino]cyclohexyl]azanium (CID 146900585) is [(1R,2S)-2-[[8-carbamoyl-7-[[5-(5-morpholin-4-yl-7-oxofuro[3,2-b]pyran-3-yl)-1H-indazol-7-yl]methyl]-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]amino]cyclohexyl]azanium.
What is the SMILES notation for [(1R,2S)-2-[[8-carbamoyl-7-[[5-(5-morpholin-4-yl-7-oxofuro[3,2-b]pyran-3-yl)-1H-indazol-7-yl]methyl]-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]amino]cyclohexyl]azanium?
The canonical SMILES for [(1R,2S)-2-[[8-carbamoyl-7-[[5-(5-morpholin-4-yl-7-oxofuro[3,2-b]pyran-3-yl)-1H-indazol-7-yl]methyl]-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]amino]cyclohexyl]azanium is NC(=O)c1c(Cc2cc(-c3coc4c(=O)cc(N5CCOCC5)oc34)cc3cn[nH]c23)nc(N[C@H]2CCCC[C@H]2[NH3+])n2cnnc12.
What is the InChIKey of [(1R,2S)-2-[[8-carbamoyl-7-[[5-(5-morpholin-4-yl-7-oxofuro[3,2-b]pyran-3-yl)-1H-indazol-7-yl]methyl]-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]amino]cyclohexyl]azanium?
The InChIKey is IYMHCMDQQVEQGZ-RTWAWAEBSA-O. The full InChI is InChI=1S/C31H32N10O5/c32-20-3-1-2-4-21(20)36-31-37-22(25(29(33)43)30-39-35-15-41(30)31)11-17-9-16(10-18-13-34-38-26(17)18)19-14-45-28-23(42)12-24(46-27(19)28)40-5-7-44-8-6-40/h9-10,12-15,20-21H,1-8,11,32H2,(H2,33,43)(H,34,38)(H,36,37)/p+1/t20-,21+/m1/s1.
What are the key properties of [(1R,2S)-2-[[8-carbamoyl-7-[[5-(5-morpholin-4-yl-7-oxofuro[3,2-b]pyran-3-yl)-1H-indazol-7-yl]methyl]-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]amino]cyclohexyl]azanium?
[(1R,2S)-2-[[8-carbamoyl-7-[[5-(5-morpholin-4-yl-7-oxofuro[3,2-b]pyran-3-yl)-1H-indazol-7-yl]methyl]-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]amino]cyclohexyl]azanium has a molecular weight of 625.67 g/mol, XLogP of 1.86, 7 rotatable bonds, 4 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for [(1R,2S)-2-[[8-carbamoyl-7-[[5-(5-morpholin-4-yl-7-oxofuro[3,2-b]pyran-3-yl)-1H-indazol-7-yl]methyl]-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]amino]cyclohexyl]azanium is sourced from PubChem (CID 146900585), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).